Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Systemic exposure of everolimus after stent implantation: a pharmacokinetic study.

Wiemer M, Seth A, Chandra P, Neuzner J, Richardt G, Piek JJ, Desaga M, Macaya C, Bol CJ, Miquel-Hebert K, De Roeck K, Serruys PW.

Am Heart J. 2008 Oct;156(4):751.e1-7. doi: 10.1016/j.ahj.2008.07.005.

PMID:
18926156
2.

Phase I clinical and pharmacologic study of chronic oral administration of the farnesyl protein transferase inhibitor R115777 in advanced cancer.

Crul M, de Klerk GJ, Swart M, van't Veer LJ, de Jong D, Boerrigter L, Palmer PA, Bol CJ, Tan H, de Gast GC, Beijnen JH, Schellens JH.

J Clin Oncol. 2002 Jun 1;20(11):2726-35.

PMID:
12039935
3.

Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933.

van Zuylen L, Sparreboom A, van der Gaast A, Nooter K, Eskens FA, Brouwer E, Bol CJ, de Vries R, Palmer PA, Verweij J.

Eur J Cancer. 2002 May;38(8):1090-9.

PMID:
12008197
4.

Evaluation of the bioequivalence of tablets and capsules containing the novel anticancer agent R115777 (Zarnestra) in patients with advanced solid tumors.

Crul M, de Klerk GJ, Swart M, Weiner L, Palmer PA, Bol CJ, Beijnen JH, Schellens JH.

Eur J Drug Metab Pharmacokinet. 2002 Jan-Mar;27(1):61-5.

PMID:
11996329
5.

Phase I and pharmacokinetic study of the orally administered farnesyl transferase inhibitor R115777 in patients with advanced solid tumors.

Punt CJ, van Maanen L, Bol CJ, Seifert WF, Wagener DJ.

Anticancer Drugs. 2001 Mar;12(3):193-7.

PMID:
11290865
6.

Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat.

Bol CJ, Vogelaar JP, Tang JP, Mandema JW.

J Pharmacol Exp Ther. 2000 Jul;294(1):347-55.

PMID:
10871332
7.

The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel.

van Zuylen L, Sparreboom A, van der Gaast A, van der Burg ME, van Beurden V, Bol CJ, Woestenborghs R, Palmer PA, Verweij J.

Clin Cancer Res. 2000 Apr;6(4):1365-71.

8.

Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer.

Zujewski J, Horak ID, Bol CJ, Woestenborghs R, Bowden C, End DW, Piotrovsky VK, Chiao J, Belly RT, Todd A, Kopp WC, Kohler DR, Chow C, Noone M, Hakim FT, Larkin G, Gress RE, Nussenblatt RB, Kremer AB, Cowan KH.

J Clin Oncol. 2000 Feb;18(4):927-41.

PMID:
10673536
9.

Anesthetic profile of dexmedetomidine identified by stimulus-response and continuous measurements in rats.

Bol CJ, Vogelaar JP, Mandema JW.

J Pharmacol Exp Ther. 1999 Oct;291(1):153-60.

PMID:
10490899
10.
11.

Determination of dexmedetomidine in rat plasma by a sensitive [3H]clonidine radioreceptor assay.

Bol CJ, IJzerman AP, Danhof M, Mandema JW.

J Pharm Sci. 1997 Jul;86(7):822-6.

PMID:
9232523

Supplemental Content

Support Center